Skip to main content
STE
NYSE Industrial Applications And Services

STERIS Reports Strong FY26 Results, Issues Positive FY27 Guidance, and Authorizes $1B Share Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$210
Mkt Cap
$19.796B
52W Low
$195.14
52W High
$269.44
52W Position info
7.6% above low
Off High info
22% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

STE is trading near its 52-week low of $195.14 (7.6% above the low).

Summary

STERIS plc announced strong fiscal year 2026 financial results, provided an optimistic outlook for fiscal year 2027, and authorized a new $1 billion share repurchase program.


Key Events · Earnings and Guidance · STE

  • Strong Fiscal 2026 Financial Performance

    STERIS reported a 9% increase in full-year fiscal 2026 revenue from continuing operations to $5.9 billion, with constant currency organic revenue growth of 7%. Adjusted diluted EPS rose to $10.17 from $9.22 in fiscal 2025, and free cash flow increased to $982.9 million.

  • Positive Fiscal 2027 Outlook

    The company anticipates fiscal 2027 revenue to increase 7-8% and constant currency organic revenue growth of 6-7%. Adjusted diluted EPS is projected to be between $11.10 and $11.30, representing a 9-11% increase over fiscal 2026.

  • New $1 Billion Share Repurchase Program

    STERIS's Board of Directors authorized a new share buyback program for up to $1 billion of ordinary shares, replacing the previous authorization. This program allows for repurchases through open market transactions, including 10b5-1 plans.

  • Strategic Investment in New Manufacturing Plant

    The company plans a strategic investment of approximately $60 million over two years to build a new sterility assurance manufacturing plant in Mentor, Ohio, expected to be operational by late calendar 2027.


Analysis · STE · Industrial Applications And Services

STERIS plc delivered robust financial performance for fiscal year 2026, with significant increases in revenue and adjusted EPS. The company's positive outlook for fiscal year 2027, projecting continued growth in both revenue and adjusted EPS, suggests ongoing operational strength. The authorization of a new $1 billion share repurchase program underscores management's confidence in the company's valuation and commitment to returning capital to shareholders.

At the time of this filing, STE was trading at $210.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $19.8B. The 52-week trading range was $195.14 to $269.44. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STE - Latest Insights

STE
Aug 07, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $237.47
Real-time Price: $237.47 info
Change: $0 (0%) info
Market Cap: $23.143B info
STE
Aug 05, 2026, 4:44 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $232.71
Real-time Price: $237.47 info
Change: +$4.76 (+2%) info
Market Cap: $23.143B info
STE
Aug 05, 2026, 8:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $232.85
Real-time Price: $237.47 info
Change: +$4.62 (+2%) info
Market Cap: $23.143B info
STE
May 29, 2026, 4:25 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $212.73
Real-time Price: $237.47 info
Change: +$24.74 (+12%) info
Market Cap: $23.143B info
STE
May 29, 2026, 4:04 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $212.73
Real-time Price: $237.47 info
Change: +$24.74 (+12%) info
Market Cap: $23.143B info